Veradermics, Incorporated(MANE)
$156.56+8.12 (+5.47%)
MANE
Veradermics, Incorporated financials statements
$156.56
At close:+8.12 (+5.47%)
Want to see MANE full AI Analyst Report?
Veradermics, Incorporated (MANE) Ratios
90 Followers
Veradermics, Incorporated Ratios
MANE's free cash flow for Q2 2026 was $-14.51M. For the 2026 fiscal year, MANE's free cash flow was decreased by $-21.00K and operating cash flow was $-14.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 16.66 | 11.77 | 5.75 |
| Quick Ratio | 16.66 | 11.77 | 5.75 |
| Cash Ratio | 2.38 | 11.25 | 5.34 |
| Solvency Ratio | -0.26 | -5.61 | -4.30 |
| Operating Cash Flow Ratio | -7.82 | -5.02 | -4.43 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -121.14M | $ 50.82M | $ 13.72M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.04 |
| Debt-to-Equity Ratio | -0.00 | 0.00 | 0.05 |
| Debt-to-Capital Ratio | -0.00 | 0.00 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.05 |
| Financial Leverage Ratio | -1.26 | 1.09 | 1.26 |
| Debt Service Coverage Ratio | 0.00 | -44.28 | -457.06 |
| Interest Coverage Ratio | 0.00 | -45.77 | -481.22 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.31 | 2.05 | 0.94 |
| Profitability Margins | |||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.75% | 98.92% | 95.19% |
| Return on Assets (ROA) | -45.86% | -44.61% | -89.35% |
| Return on Equity (ROE) | 57.84% | -48.46% | -112.81% |
| Return on Capital Employed (ROCE) | -50.43% | -48.99% | -112.46% |
| Return on Invested Capital (ROIC) | -50.43% | -48.99% | -112.46% |
| Return on Tangible Assets | -45.86% | -44.61% | -89.35% |
| Earnings Yield | -248.89% | -0.35% | -0.22% |
| Efficiency Ratios | |||
| Receivables Turnover | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | -96.11 | -0.12 | -0.07 |
| Free Cash Flow Per Share | -96.14 | -0.12 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -2983.42 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -2983.42 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -17900.50 | 0.00 | -17.19 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -254.68% | -0.31% | -0.18% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -0.34 | -269.64 | -460.91 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.23 | 139.04 | 519.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.39 | -320.85 | -562.57 |
| Price-to-Operating Cash Flow Ratio | -0.39 | -320.85 | -562.57 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -3.80 | 0.00 |
| Enterprise Value Multiple | -0.09 | -291.37 | -460.97 |
| Enterprise Value | 6.36M | 7.55B | 7.58B |
| EV to EBITDA | -0.09 | -291.37 | -460.97 |
| EV to Sales | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.09 | -318.61 | -561.43 |
| EV to Operating Cash Flow | -0.09 | -318.61 | -561.43 |
| Tangible Book Value Per Share | -162.44 | 0.27 | 0.07 |
| Shareholders’ Equity Per Share | -162.44 | 0.27 | 0.07 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -93.95 | -0.13 | -0.08 |
| Tax Burden | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.02 | 0.89 | 0.82 |
Currency in USD
